Copyright
©The Author(s) 2023.
World J Virol. Jun 25, 2023; 12(3): 136-150
Published online Jun 25, 2023. doi: 10.5501/wjv.v12.i3.136
Published online Jun 25, 2023. doi: 10.5501/wjv.v12.i3.136
Virus | Route of infection | Population affected | Type of disease | Diagnosis | Treatment |
Norovirus | Fecal-oral, fomites | Children < 5 yr | Gastroenteritis | Self-limited | Supportive |
Rotavirus | Fecal-oral, fomites | Children < 5 yr | Gastroenteritis | Self-limited | Supportive |
Adenovirus | Fecal-oral, fomites | Any age group, especially children | Gastroenteritis | Self-limited | Supportive |
Hepatitis A | Fecal-oral, fomites | Any age groups; international travelers to endemic countries, IV drug users, men who have sex with men | Gastroenteritis, acute viral hepatitis, and fulminant liver failure | Serology | Supportive |
Astrovirus | Fecal-oral, fomites | Children < 5 yr | Gastroenteritis | Self-limited | Supportive |
Sapovirus | Fecal-oral, fomites | Children < 5 yr | Gastroenteritis | Self-limited | Supportive |
Coronavirus | Fecal-oral, fomites | Any age group | Gastroenteritis; respiratory infection | Self-limited, viral rapid antigen, PCR can be performed | Supportive; for COVID-19-antivirals (nirmatrelvir/ritonavir, remdesivir), steroids, biologics (tocilizumab, baricitinib) |
Hepatitis E | Fecal-oral, Fomites | 15-40 yr | Gastroenteritis, acute hepatitis, and acute liver failure | Serology | Supportive |
Cytomegalovirus | Contact with bodily fluids and organ transplantation | All ages | Colitis, toxic megacolon, and peritonitis | Viral PCR | Ganciclovir, valganciclovir, ganciclovir resistant-foscarnet, cidofovir |
Herpes simplex virus | Sexual contact | MSM | Proctitis and anal ulcerations | Viral PCR | Acyclovir, valacyclovir, and famciclovir |
HIV | Contact through bodily fluids like sexual contact, injection drug use, perinatal transmission | All ages | Acquired immunodeficiency syndrome, HIV enteropathy-diarrhea | 2-step testing-combination antigen-antibody test followed by HIV 1/2 differentiation assay | HAART-combination therapy with Tenofovir, Emtricitabine, raltegravir, and bictegravir |
Hepatitis B and D | Contact through bodily fluids like sexual contact, injection drug use, perinatal transmission | Usually adults, but all age groups can be affected | Hepatitis, cirrhosis, hepatocellular carcinoma | Serology, DNA load | Acute infections usually resolve; in some cases, tenofovir, entecavir |
Hepatitis C | Contact through bodily fluids like sexual contact, injection drug use, transfusion, or perinatal transmission | Usually adults, but all age groups can be affected | Hepatitis, cirrhosis, hepatocellular carcinoma | Serology, RNA load | Combination therapy specific for genotypes; includes sofosbuvir/velpatasvir, glecaprevir/pibrentasvir |
Varicella Zoster | Droplet, and contact infection | Commonly in children but can occur in any age group. Reactivation common in immunocompromised | Erosive disease of the stomach and intestines, motility problems | Clinical diagnosis, but RNA PCR is used for atypical presentations | Acyclovir, valacyclovir, and brivudin |
Epstein-Barr virus | Contact with bodily fluids, especially saliva; sexual transmission, blood transfusion, organ transplantation | Individuals aged 15-24 yr | Gastritis, Enteritis, esophageal disorders, and gastric cancer | Mostly clinical diagnosis but can be diagnosed by serology | Symptomatic treatment, acyclovir in some cases |
HHV-8 | Sexual transmission, contact with saliva, blood transfusion, and organ transplantation | All age groups | Maculopapular and polypoid lesions of the GI tract | Endoscopy and biopsy | Radiation, intralesional chemotherapy, or systemic chemotherapy with liposomal doxorubicin and paclitaxel |
HPV | Sexual transmission-oral, vaginal, anal sex | 15-49 yr | Oropharyngeal, esophageal, gastric, colorectal, and anal cancers | Cytology and viral testing | Cancer-specific treatment |
- Citation: Jagirdhar GSK, Pulakurthi YS, Chigurupati HD, Surani S. Gastrointestinal tract and viral pathogens. World J Virol 2023; 12(3): 136-150
- URL: https://www.wjgnet.com/2220-3249/full/v12/i3/136.htm
- DOI: https://dx.doi.org/10.5501/wjv.v12.i3.136